263 related articles for article (PubMed ID: 17065350)
61. Differences in susceptibility to develop parameters of diabetic nephropathy in four mouse strains with type 1 diabetes.
Franzén S; Friederich-Persson M; Fasching A; Hansell P; Nangaku M; Palm F
Am J Physiol Renal Physiol; 2014 May; 306(10):F1171-8. PubMed ID: 24623147
[TBL] [Abstract][Full Text] [Related]
62. Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy.
Elmarakby AA; Sullivan JC
Cardiovasc Ther; 2012 Feb; 30(1):49-59. PubMed ID: 20718759
[TBL] [Abstract][Full Text] [Related]
63. Selective Rac-1 inhibition protects from diabetes-induced vascular injury.
Vecchione C; Aretini A; Marino G; Bettarini U; Poulet R; Maffei A; Sbroggiò M; Pastore L; Gentile MT; Notte A; Iorio L; Hirsch E; Tarone G; Lembo G
Circ Res; 2006 Feb; 98(2):218-25. PubMed ID: 16357302
[TBL] [Abstract][Full Text] [Related]
64. Upregulation of PKC genes and isozymes in cardiovascular tissues during early stages of experimental diabetes.
Guo M; Wu MH; Korompai F; Yuan SY
Physiol Genomics; 2003 Jan; 12(2):139-46. PubMed ID: 12441406
[TBL] [Abstract][Full Text] [Related]
65. Effects of streptozotocin-induced diabetes and physical training on gene expression of extracellular matrix proteins in mouse skeletal muscle.
Lehti TM; Silvennoinen M; Kivelä R; Kainulainen H; Komulainen J
Am J Physiol Endocrinol Metab; 2006 May; 290(5):E900-7. PubMed ID: 16352670
[TBL] [Abstract][Full Text] [Related]
66. SIRT1 reduction causes renal and retinal injury in diabetes through endothelin 1 and transforming growth factor β1.
Mortuza R; Feng B; Chakrabarti S
J Cell Mol Med; 2015 Aug; 19(8):1857-67. PubMed ID: 25753689
[TBL] [Abstract][Full Text] [Related]
67. Increased renal hypertrophy in diabetic mice genetically modified at the haptoglobin locus.
Miller-Lotan R; Herskowitz Y; Kalet-Litman S; Nakhoul F; Aronson D; Zoabi R; Asaf R; Ben-Izhak O; Sabo E; Lim SK; Baumann H; Berger FG; Levy AP
Diabetes Metab Res Rev; 2005; 21(4):332-7. PubMed ID: 15852445
[TBL] [Abstract][Full Text] [Related]
68. Deletion of p66Shc longevity gene protects against experimental diabetic glomerulopathy by preventing diabetes-induced oxidative stress.
Menini S; Amadio L; Oddi G; Ricci C; Pesce C; Pugliese F; Giorgio M; Migliaccio E; Pelicci P; Iacobini C; Pugliese G
Diabetes; 2006 Jun; 55(6):1642-50. PubMed ID: 16731826
[TBL] [Abstract][Full Text] [Related]
69. [Protein kinase C-betaI, betaII in mouse diabetic nephropathy kidney and its relation to nephroprotective actions of the angiotensin receptor blocker telmisartan].
Yao LJ; Wang JQ; Deng AG; Liu JS
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(28):1991-5. PubMed ID: 17923043
[TBL] [Abstract][Full Text] [Related]
70. Attenuation of extracellular matrix accumulation in diabetic nephropathy by the advanced glycation end product cross-link breaker ALT-711 via a protein kinase C-alpha-dependent pathway.
Thallas-Bonke V; Lindschau C; Rizkalla B; Bach LA; Boner G; Meier M; Haller H; Cooper ME; Forbes JM
Diabetes; 2004 Nov; 53(11):2921-30. PubMed ID: 15504973
[TBL] [Abstract][Full Text] [Related]
71. Protein kinase C beta inhibition attenuates the progression of experimental diabetic nephropathy in the presence of continued hypertension.
Kelly DJ; Zhang Y; Hepper C; Gow RM; Jaworski K; Kemp BE; Wilkinson-Berka JL; Gilbert RE
Diabetes; 2003 Feb; 52(2):512-8. PubMed ID: 12540629
[TBL] [Abstract][Full Text] [Related]
72. Hyperglycemia induced down-regulation of renal P-glycoprotein expression.
Yeh SY; Pan HJ; Lin CC; Kao YH; Chen YH; Lin CJ
Eur J Pharmacol; 2012 Sep; 690(1-3):42-50. PubMed ID: 22721613
[TBL] [Abstract][Full Text] [Related]
73. [The role of protein kinase C in the pathophysiology of diabetic retinopathy].
Lang GE; Kampmeier J
Klin Monbl Augenheilkd; 2002 Nov; 219(11):769-76. PubMed ID: 12494366
[TBL] [Abstract][Full Text] [Related]
74. Mechanisms of antioxidant and pro-oxidant effects of alpha-lipoic acid in the diabetic and nondiabetic kidney.
Bhatti F; Mankhey RW; Asico L; Quinn MT; Welch WJ; Maric C
Kidney Int; 2005 Apr; 67(4):1371-80. PubMed ID: 15780089
[TBL] [Abstract][Full Text] [Related]
75. Increasing of oxidative stress from mitochondria in type 2 diabetic patients.
Nakanishi S; Suzuki G; Kusunoki Y; Yamane K; Egusa G; Kohno N
Diabetes Metab Res Rev; 2004; 20(5):399-404. PubMed ID: 15343586
[TBL] [Abstract][Full Text] [Related]
76. Pathogenesis of diabetic nephropathy: the role of oxidative stress and protein kinase C.
Ha H; Kim KH
Diabetes Res Clin Pract; 1999 Sep; 45(2-3):147-51. PubMed ID: 10588367
[TBL] [Abstract][Full Text] [Related]
77. Role of TGF-beta in pathogenesis of diabetic nephropathy.
Pantsulaia T
Georgian Med News; 2006 Feb; (131):13-8. PubMed ID: 16575121
[TBL] [Abstract][Full Text] [Related]
78. Nox-4 deletion reduces oxidative stress and injury by PKC-α-associated mechanisms in diabetic nephropathy.
Thallas-Bonke V; Jha JC; Gray SP; Barit D; Haller H; Schmidt HH; Coughlan MT; Cooper ME; Forbes JM; Jandeleit-Dahm KA
Physiol Rep; 2014 Nov; 2(11):. PubMed ID: 25367693
[TBL] [Abstract][Full Text] [Related]
79. Microarray analysis of the effects of a gamma-protein kinase C null mutation on gene expression in striatum: a role for transthyretin in mutant phenotypes.
Smith AM; Bowers BJ; Radcliffe RA; Wehner JM
Behav Genet; 2006 Nov; 36(6):869-81. PubMed ID: 16767509
[TBL] [Abstract][Full Text] [Related]
80. Translocation of glomerular p47phox and p67phox by protein kinase C-beta activation is required for oxidative stress in diabetic nephropathy.
Kitada M; Koya D; Sugimoto T; Isono M; Araki S; Kashiwagi A; Haneda M
Diabetes; 2003 Oct; 52(10):2603-14. PubMed ID: 14514646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
